Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis

被引：0
作者：
Jong Hwan Choi
Woo Jin Chung
Si Hyun Bae
Do Seon Song
Myeong Jun Song
Young Seok Kim
Hyung Joon Yim
Young Kul Jung
Sang Jun Suh
Jun Yong Park
Do Young Kim
Seung Up Kim
Sung Bum Cho
机构：
[1] Keimyung University School of Medicine,Department of Internal Medicine
[2] The Catholic University of Korea,Department of Internal Medicine, College of Medicine
[3] Soonchunhyang University Bucheon Hospital,Department of Internal Medicine
[4] Korea University Ansan Hospital,Department of Internal Medicine
[5] Yonsei University College of Medicine,Department of Internal Medicine
[6] Chonnam National University Medical School,Department of Internal Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 82卷
关键词：
Hepatocellular carcinoma; Portal vein tumor thrombosis; Sorafenib; Hepatic arterial infusion chemotherapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：469 / 478
页数：9
相关论文
共 50 条
  • [31] Induction hepatic arterial infusion chemotherapy followed by surgery for hepatocellular carcinoma with massive portal vein tumor thrombosis: a case series of 20 patients
    Yuta Kimura
    Yukio Tokumitsu
    Yoshitaro Shindo
    Hiroto Matsui
    Satoshi Matsukuma
    Issei Saeki
    Taro Takami
    Takahiro Yamasaki
    Tatsuya Ioka
    Hiroaki Nagano
    Journal of Medical Case Reports, 19 (1)
  • [32] The efficacy of hepatic arterial infusion chemotherapy as an alternative to sorafenib in advanced hepatocellular carcinoma
    Jeong, Soung Won
    Jang, Jae Young
    Lee, Ji Eun
    Lee, Sae Hwan
    Kim, Sang Gyune
    Cha, Sang-Woo
    Kim, Young Seok
    Cho, Young Deok
    Kim, Hong Soo
    Kim, Boo Sung
    Kim, Kyoung Ha
    Kim, Yong Jae
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (02) : 164 - 171
  • [33] Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Cheong, JY
    Lee, KM
    Cho, SW
    Won, JH
    Kim, JK
    Wang, HJ
    Hahm, KB
    Kim, JH
    HEPATOLOGY RESEARCH, 2005, 32 (02) : 127 - 133
  • [34] A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
    Masafumi Ikeda
    Takuji Okusaka
    Junji Furuse
    Shuichi Mitsunaga
    Hideki Ueno
    Hidekazu Yamaura
    Yoshitaka Inaba
    Yoshito Takeuchi
    Mitsuo Satake
    Yasuaki Arai
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 463 - 470
  • [35] Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
    Lyu, Ning
    Kong, Yanan
    Mu, Luwen
    Lin, Youen
    Li, Jibin
    Liu, Yaru
    Zhang, Zhenfeng
    Zheng, Lie
    Deng, Haijing
    Li, Shaolong
    Xie, Qiankun
    Guo, Rongping
    Shi, Ming
    Xu, Li
    Cai, Xiuyu
    Wu, Peihong
    Zhao, Ming
    JOURNAL OF HEPATOLOGY, 2018, 69 (01) : 60 - 69
  • [36] Efficacy and safety of sorafenib plus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
    Regmi, Parbatraj
    Hu, Hai-Jie
    Lv, Tian-Run
    Paudyal, Aliza
    Sah, Ram Babu
    Ma, Wen-Jie
    Jin, Yan-Wen
    Li, Fu-Yu
    SURGICAL ONCOLOGY-OXFORD, 2021, 39
  • [37] Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method
    Fukubayashi, Kotaro
    Tanaka, Motohiko
    Izumi, Kazuhiro
    Watanabe, Takehisa
    Fujie, Satomi
    Kawasaki, Takeshi
    Yoshimaru, Yoko
    Tateyama, Masakuni
    Setoyama, Hiroko
    Naoe, Hideaki
    Kikuchi, Ken
    Sasaki, Yutaka
    CANCER MEDICINE, 2015, 4 (08): : 1214 - 1223
  • [38] Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Arai, Kuniaki
    Sunagozaka, Hajime
    Kitahara, Masaaki
    Nakagawa, Hidetoshi
    Kagaya, Takashi
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2014, 44 (12) : 1179 - 1185
  • [39] Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
    Yang Zhao
    Jia Ying Lai
    Run Bin Liang
    Min Ke He
    Ming Shi
    Journal of Interventional Medicine, 2019, (02) : 78 - 83
  • [40] Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
    Ikeda, M.
    Shimizu, S.
    Sato, T.
    Morimoto, M.
    Kojima, Y.
    Inaba, Y.
    Hagihara, A.
    Kudo, M.
    Nakamori, S.
    Kaneko, S.
    Sugimoto, R.
    Tahara, T.
    Ohmura, T.
    Yasui, K.
    Sato, K.
    Ishii, H.
    Furuse, J.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2016, 27 (11) : 2090 - 2096
12345